参考文献/References:
[1]ONISHI Y.Aplastic anemia:History and recent developments in diagnosis and treatment[J].Int J Hematol,2024,119(3):217-219.
[2]PESLAK S A,OLSON T,BABUSHOK D V.Diagnosis and treatment of aplastic anemia[J].Curr Treat Options Oncol,2017,18(12):70.
[3]WESTON W,GUPTA V,ADKINS R,et al.New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia[J].Immunol Res,2013,57(1-3):34-43.
[4]PEFFAULT D,ELATOUR R,KULASEKARARAJ A,et al.Eltrombopag added to immunosuppression in severe aplastic anemia[J].N Engl J Med,2022,386(1):11-23.
[5]冀晓红,李草旎,杨学民,等.中西医结合治疗慢性再生障碍性贫血的临床疗效及不良反应分析[J].中华中医药学刊,2016,34(12):3027-3029.
[6]叶宝东,李杭超.中西医结合治疗再生障碍性贫血[J].中国实用内科杂志,2023,43(7):551-555.
[7]梁钰莹,万宛若,谢滟,等.中药复方及成分改善再生障碍性贫血机制研究进展[J].世界科学技术-中医药现代化,2025,27(1):168-178.
[8]王东军,田之魁,焦锟,等.《金匮要略·血痹虚劳病脉证并治》虚劳病精气神调治原则与方法[J].天津中医药,2022,39(4):466-469.
[9]黄佳红.基于数据挖掘对现代名中医治疗慢性再生障碍性贫血医案分析[D].南宁:广西中医药大学,2023.
[10]杨旭娜,梁太守,李思琦.试论《黄帝内经》“致中和”思想在虚劳疾病中的体现与运用[J].中医临床研究,2024,16(25):31-34.
[11]周郁鸿.中医药治疗慢性再生障碍性贫血研究述评[J].北京中医药大学学报,2023,46(10):1461-1466.
[12]符坤,胡素敏.缪希雍吐血证治特点探讨[J].江西中医药,2011,42(11):11-12.
[13]陈信义,陈珮.中医治疗血液病名家学术观点撷菁[J].北京中医药,2021,40(5):466-469.
[14]许凯凯,田露.《黄帝内经》“食气入胃”新解[J].中医学报,2021,36(11):2293-2296.
[15]张建梅.从肝论治再生障碍性贫血的理论探讨[J].中医临床研究,2017,9(1):48-49.
[16]陈源,李振华,张效科.冲脉为病的临证辨治思路探析[J].中医杂志,2025,66(4):354-357,366.
[17]唐颖慧,李粉萍,薛敬东,等.张氏肝病流派从“补肝体强肝用”辨治臌胀[J].陕西中医,2022,43(6):763-766.
[18]李凯,李秘.从肝体阴用阳解析《伤寒论》厥阴病篇[J].河南中医,2020,40(2):163-166.
[19]高尚轸,李平平,李耀辉.从《临证指南医案》探究叶天士治肝特色[J].中西医结合肝病杂志,2021,31(5):455-456.
[20]陈东方,郑丽红.肝“体阴用阳”理论与肝硬化渐进性进展解析[J].浙江中医药大学学报,2025,49(1):34-39.
[21]唐晓勇,孙振高,唐由君.再生障碍性贫血从肝论治探微[J].中医杂志,2003,15(3):165-166.
[22]何流,钱会南.论肝之体阴用阳及临床应用[J].安徽中医药大学学报,2016,35(2):1-4.
[23]王兵.《不居集》治疗虚损学术特色与经验探析[D].合肥:安徽中医药大学,2022.
[24]张盛琪,丁晓庆,廖俊尧,等.基于“治血治气,以脾为主”理论探讨慢性/难治性原发免疫性血小板减少症的临床辨治[J].北京中医药,2023,42(7):789-791.
[25]郝亚非,徐光星.基于六经气化学说的张志聪三阳阳明病浅析[J].浙江中医药大学学报,2023,47(5):479-482,489.
[26]黄振翘,黄韬,周永明,等.补肾泻肝方治疗再生障碍性贫血的临床研究[J].上海中医药大学学报,2000,18(1):20-24.
[27]张开波,张璐鹏,李治兵,等.唐容川论治血证特色经验探析[J].中国民间疗法,2022,30(1):16-18.
[28]周怡驰.基于《内经》肾脾肝同源同治理论对再障的治疗研究[D].成都:成都中医药大学,2018.
[29]李达,刘琨,胡永珍,等.调和肝脾方辅助造血干细胞移植治疗血液系统疾病的临床研究[J].中国中西医结合杂志,2011,31(5):626-630.
相似文献/References:
[1]唐洪屈,刘 娜△,刘 勇,等.从脾肾论治熟地黄在慢性再生障碍性贫血治疗中的应用*[J].陕西中医,2020,(6):780.[doi:DOI:10.3969/j.issn.10007369.2020.06.022]
[2]黄莉荣,薛 征.基于Th1/Th2失衡探讨再生障碍性贫血中西医治疗研究进展[J].陕西中医,2021,(11):1644.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.034]
HUANG Lirong,XUE Zheng.Discussion on treatment progress of traditional Chinese and western medicine of aplastic anemia based on Th1/Th2[J].,2021,(1):1644.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.034]
[3]李 芮,刘 健,靳 楠,等.基于网络药理学探讨当归补血汤治疗再生障碍性贫血作用机制[J].陕西中医,2022,(3):384.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.028]
[4]杨 桐,田春洪,田 原,等.益血生髓颗粒对苯试剂诱导的再生障碍性贫血小鼠造血功能及T细胞亚群的影响[J].陕西中医,2022,(8):1019.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.007]
YANG Tong,TIAN Chunhong,TIAN Yuan,et al.Effects of Yixue Shengsui granule on hematopoietic function and T cell subsets of benzene reagent-induced aplastic anermia model mice[J].,2022,(1):1019.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.007]
[5]何昊兰,鲁英娟,张小莉,等.健脾生血汤联合促红素治疗再生障碍性贫血疗效及对患者中医症候、炎症因子水平的影响[J].陕西中医,2022,(10):1411.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.021]
HE Haolan,LU Yingjuan,ZHANG Xiaoli,et al.Effect of Jianpi Shengxue decoction combined with erythropoietin on aplastic anemia and its effect on TCM symptoms and inflammatory factors[J].,2022,(1):1411.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.021]
[6]李玎玎,何丹迪,王金环.基于“虫子学说”探讨中医药对再生障碍性贫血免疫调控的研究进展[J].陕西中医,2025,46(8):1136.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.026]
LI Dingding,HE Dandi,WANG Jinhuan.Exploring the research progress of traditional Chinese medicine on immune regulation of aplastic anemia from insect theories[J].,2025,46(1):1136.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.026]